Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Po Ming Ku"'
Autor:
Wen‐Tung Wu, Chun‐Teng Tsai, Yu‐Ching Chou, Po‐Ming Ku, Yong‐Chen Chen, San‐Lin You, Chi‐Feng Hung, Chien‐An Sun
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 20 (2019)
Background Recent studies have raised concerns about the reduced efficacy of citalopram when used concurrently with proton pump inhibitors. The aim of this study was to evaluate the associations between clinical use of citalopram and omeprazole and t
Externí odkaz:
https://doaj.org/article/c56ced36c63b4c65975aca580baabab6
Autor:
Chieh-Hua Lu, Feng-Chih Kuo, Chien-An Sun, Fu-Huang Lin, Chang-Hsun Hsieh, Chien-Hsing Lee, Je-Ming Hu, Jhih-Syuan Liu, Cheng-Chiang Su, Tai-Wen Wang, Po-Ming Ku, Yu-Ching Chou, Chia-Luen Huang, Yong-Chen Chen
Publikováno v:
Journal of Investigative Medicine. 69:1161-1167
Chronic inflammation, a hallmark of gout, is implicated in the pathogenesis of atherosclerosis. Thus, in theory, gout can be expected to increase the risk of acute myocardial infarction (AMI). Yet, results from several epidemiological studies have be
Autor:
Hsuan-Fu Kuo, Po-Len Liu, Inn-Wen Chong, Yu-Peng Liu, Yung-Hsiang Chen, Po-Ming Ku, Chia-Yang Li, Hsiu-Hua Chen, Hui-Ching Chiang, Chiao-Lin Wang, Huang-Jen Chen, Yen-Chieh Chen, Chong-Chao Hsieh
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156059 (2016)
Pigment epithelium-derived factor (PEDF) is a multifunctional protein that exhibits anti-angiogenic, antitumor, anti-inflammatory, antioxidative, anti-atherogenic, and cardioprotective properties. While it was recently shown that PEDF expression is i
Externí odkaz:
https://doaj.org/article/5033ec887a4a4fe38061a94f34232dbf
Autor:
Po-Yen, Huang1, Po-Ming, Ku1
Publikováno v:
Case Reports in Cardiology. 3/9/2017, p1-4. 4p.
Autor:
Chi-Feng Hung, Wen-Tung Wu, San Lin You, Yong-Chen Chen, Chun‐Teng Tsai, Chien-An Sun, Po-Ming Ku, Yu-Ching Chou
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Recent studies have raised concerns about the reduced efficacy of citalopram when used concurrently with proton pump inhibitors. The aim of this study was to evaluate the associations between clinical use of citalopram and omeprazole and t
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 389:1215-1223
Amarogentin is a bitter-tasting secoiridoid glycoside isolated from an herb. Inhibition of aldose reductase by amarogentin has been documented as an antidiabetic action. However, the mechanisms of action of amarogentin in diabetic disorders remain un
Autor:
Chia-Luen Huang, Tai-Wen Wang, Yong-Chen Chen, Je-Ming Hu, Po-Ming Ku, Chang-Hsun Hsieh, Chien-Hsing Lee, Feng-Chih Kuo, Chieh-Hua Lu, Cheng-Chiang Su, Jhih-Syuan Liu, Fu-Huang Lin, Yu-Ching Chou, Chien-An Sun
Publikováno v:
Journal of Investigative Medicine (Sage Publications Inc.); Aug2021, Vol. 69 Issue 6, p1161-1167, 7p
Autor:
Po-Ming Ku, Yap Hui Yi
Publikováno v:
Journal of the American College of Cardiology. 73:S192-S193
Patient Initials or Identifier Number 17220898 ### Relevant Clinical History and Physical Exam 67 F, with exertional angina class II for 2 months and a positive treadmill exercise test. Her risk factors included: post menopause, hypertension, dyslipi
Publikováno v:
Molecular Medicine Reports.
The signal transducer and activator of transcription 3 (STAT3) is known to be involved in hypertrophy and fibrosis in cardiac dysfunction. The activation of STAT3 via the phosphorylation of STAT3 is required for the production of functional activity.
Publikováno v:
Archives of medical research. 48(1)
Background and Aims Cardiac dysryhthmias and death are reported after loperamide abuse. The mechanism of death is not clear and cardiac depression may play a role in this mechanism. Loperamide is widely used as an agonist of the μ-opioid receptor (M